Breaking News

Samsung BioLogics Achieves Regulatory Milestone

Becomes first in South Korean pharma industry to achieve ISO 22301 certificate

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Samsung BioLogics has received ISO 22301 certificate, the international standard Business Continuity Management System (BCMS), from BSI (British Standards Institution), a global certification association. They are the first South Korean company to do so. ISO 22301 certificate is a comprehensive standard published by the International Organization for Standardization (ISO) that represents the highest level of commitment to business continuity and disaster preparedness. In the case of biopha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters